[1] 贺兴云,周任远.内源性雄激素调节的新靶点和新进展[J].中华医学杂志,2016,96(36):2940-2942.[2] Nagahashi M, Yamada A, Miyazaki H,et al. Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods. J Mammary Gland Biol Neoplasia. 2016; 21(1-2):9-17.[3] 叶茂飞,张正望.睾丸间质细胞瘤1例报告及文献复习[J].现代泌尿外科杂志,2015,20(2):122.[4] 吴炎,王薇,周宇,等.雄激素替代治疗对糖尿病合并男性迟发性性腺功能减退症的疗效[J].中国老年学杂志,2015,35(13): 3578-3580.[5] 鞠长亮,王小林,乔磊.促性腺激素治疗男性低促性腺激素性性腺功能减退症的疗效评估[J].中国社区医师,2015,31(9):14,16.[6] 刘明锴,杨文增,马涛,等.骨髓间充质干细胞移植对睾丸间质细胞再生及睾酮分泌的影响[J].中国组织工程研究,2017,21(1): 66-70. [7] 邢晓宇,范继桃,张志远,等.条件培养液诱导人脐带间充质干细胞分化为Leydig细胞的实验研究[J].中华男科学杂志,2015,21(1): 11-16.[8] Ra JC, Jeong EC, Kang SK, et al. A Prospective, Nonrandomized, no Placebo-Controlled, Phase I/II Clinical Trial Assessing the Safety and Efficacy of Intramuscular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Patients With Severe Buerger's Disease. Cell Med. 2016;9(3):87-102. [9] Jurado M, De La Mata C, Ruiz-García A, et al. Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study. Cytotherapy. 2017;19(8):927-936.[10] 安媛,张铮,杜彬,等.低温保存对围生期间充质干细胞生物学特性的影响[J].中国医药导报,2017,14(2):4-7.[11] 闫秀文.bFGF 对大鼠骨髓间充质干细胞向睾丸间质细胞分化的作用研究[D].太原:山西医科大学,2015.[12] 赵宇,杨民.脂肪间充质干细胞向成骨细胞分化的研究进展[J].局解手术学杂志,2016,25(9):694-696.[13] 徐楠,孙强,王晨超,等.脂肪间充质干细胞移植治疗兔耳静脉淤血皮瓣的实验研究[J].中国美容整形外科杂志,2015,26(2):68-71.[14] Galeano-Garces C, Camilleri ET, Riester SM, et al. Molecular Validation of Chondrogenic Differentiation and Hypoxia Responsiveness of Platelet-Lysate Expanded Adipose Tissue-Derived Human Mesenchymal Stromal Cells. Cartilage.2017;8(3):283-299.[15] 胡继军,胡晶琼,罗敏,等.脂肪间充质干细胞培养上清对脑胶质瘤细胞凋亡、侵袭的影响[J]. 武汉大学学报:医学版,2016,37(1): 63-66,80.[16] 徐文丹,崔毓桂.睾丸间质干细胞分化和移植[J].生殖医学杂志, 2016,25(4):369-373.[17] 周英晋,邢新,王晓云,等.共培养诱导骨髓间充质干细胞向睾丸间质细胞分化的研究[J].中国美容整形外科杂志,2012,23(1): 56-60.[18] Gherghiceanu M, Popescu LM. Interstitial Cajal-like cells (ICLC) in human resting mammary gland stroma. Transmission electron microscope (TEM) identification. J Cell Mol Med. 2005;9(4):893-910.[19] 刘建中,郭海彬,邓春华,等.大鼠睾丸Leydig细胞的培养和鉴定[J].中华男科学杂志,2006,12(1):14-17.[20] 杨念钦,王国民.HCG、FSH联合治疗低促性腺激素性性腺功能减退症29例报告[J].中国男科学杂志,2009,23(12):39-41.[21] Velipasalar O, Kocoglu H, Hursitoglu M, et al. A young woman with metastatic colon cancer presenting with elevated serum beta human chorionic gonadotropin. J BUON. 2017;22(3):805-806. [22] Rao CV. Protective Effects of Human Chorionic Gonadotropin Against Breast Cancer: How Can We Use This Information to Prevent/Treat the Disease. Reprod Sci. 2017;24(8): 1102-1110.[23] Yamada S, Nagai N, Saijo S, et al. Controlled basic fibroblast growth factor release device made of poly(ethyleneglycol) dimethacrylates for creating a subcutaneous neovascular bed for cell transplantation. J Biomed Mater Res A. 2017;105(11): 3017-3024.[24] 黄静,李毅,兰柳艳,等.重组牛碱性成纤维细胞生长因子治疗化疗致儿童口腔溃疡的疗效观察[J].吉林医学,2015,36(4):779-780.[25] 陈琳,张玉琪,左焕琮.神经生长因子和碱性成纤维细胞生长因子在周围神经修复应用中的研究进展[J].中华神经外科杂志,2016, 32(2):207-209.[26] 竹梅,侯倩伶,狄贯腾,等.微波硫灯、热辐射灯、日光灯和LED灯对雄性抑郁大鼠生殖功能的影响[J].基础医学与临床,2017, 37(6):821-827.[27] 董瑶瑶.白藜芦醇通过抑制人和大鼠3β-HSD干扰睾丸间质细胞产生雄激素的研究[D]. 温州:温州医科大学,2016.[28] 顾家望,冯亮,贝雷鸣,等.个体化睾酮替代疗法在迟发性性腺功能减退症中的临床应用[J].江西医药,2016,51(4):330-332.[29] Haider KS, Haider A, Doros G, et al. Long-Term Testosterone Therapy Improves Urinary and Sexual Function and Quality of Life in Men with Hypogonadism: Results from a Propensity Matched Subgroup of a Controlled Registry Study. J Urol. 2017 Jul 18. pii: S0022-5347(17)77145-5. [Epub ahead of print][30] Haider A, Meergans U, Traish A, et al. Progressive Improvement of T-Scores in Men with Osteoporosis and Subnormal Serum Testosterone Levels upon Treatment with Testosterone over Six Years. Int J Endocrinol. 2014;2014: 496948.[31] Wang YJ, Zhan JK, Huang W, et al. Effects of low-dose testosterone undecanoate treatment on bone mineral density and bone turnover markers in elderly male osteoporosis with low serum testosterone. Int J Endocrinol. 2013;2013:570413.[32] Saadiah Abdul Razak H, Shuid AN, Naina Mohamed I. Combined Effects of Eurycoma longifolia and Testosterone on Androgen-Deficient Osteoporosis in a Male Rat Model. Evid Based Complement Alternat Med. 2012;2012:872406.[33] Sinnesael M, Callewaert F, Morreels M, et al. 7α-methyl-19-nortestosterone vs. testosterone implants for hypogonadal osteoporosis: a preclinical study in the aged male orchidectomized rat model. Int J Androl. 2011;34 (6 Pt 2):e601-611.[34] Kawate H, Takayanagi R. Secondary osteoporosis UPDATE. Treatment of male osteoporosis. Testosterone replacement therapy etc. Clin Calcium. 2010;20(5):744-751.[35] Chin KY, Ima-Nirwana S. Effects of annatto-derived tocotrienol supplementation on osteoporosis induced by testosterone deficiency in rats. Clin Interv Aging. 2014;9: 1247-1259. |